Synartro Overview

  • Founded
  • 2011
  • Status
  • Acquired/​Merged
  • Employees
  • 1
  • Latest Deal Type
  • Seed
  • Latest Deal Amount
  • $700K
Latest Deal Amount
  • Investors
  • 2

Synartro General Information


Developer of drugs and a drug delivery platform intended to treat osteoarthritis in humans and animals. The company develops improved treatments using patented delivery technology that enables a sustained drug release combined with existing proven drugs, thereby enabling clinicians to slow down or stop the disease progression entirely.

Contact Information

Ownership Status
(Operating Subsidiary)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Parent Company
Primary Office
  • Gustav III Boulevard 34, 4 tr
  • 169 73 Solna
  • Sweden
+46 073-433 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Synartro Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 05-May-2020 $700K 00000 Completed Startup
1. Merger/Acquisition 18-Mar-2015 Completed Startup
To view Synartro’s complete valuation and funding history, request access »

Synartro Executive Team (3)

Name Title Board Seat Contact Info
Mia Brundin Chief Executive Officer
Fredrik Lehmann Ph.D Founder & Chairman
You’re viewing 2 of 3 executive team members. Get the full list »

Synartro Board Members (2)

Name Representing Role Since
Fredrik Lehmann Ph.D Self Founder & Chairman 000 0000
Tobias Thornblad Self Board Member 000 0000
To view Synartro’s complete board members history, request access »

Synartro Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial